2024-11-22 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**1. Performance Relative to S&P 500 (VOO):**

Intuitive Surgical Inc. (ISRG) is a company that manufactures and sells da Vinci surgical systems and related instruments and accessories.  The cumulative return for ISRG is 343.59%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 126.85%.  The difference is 216.74%, placing it at the 100th percentile of its historical relative performance against the S&P 500 based on the provided data.

The provided Alpha and Beta analysis shows consistently high Alpha values (generally above 1.0), indicating significant outperformance relative to the market benchmark (S&P 500), though this is subject to the limitations of the specific periods analyzed.  The Beta values, mostly around 1.2-1.4, suggest a relatively higher volatility compared to the overall market.  Note that the analysis period doesn't cover a market crash, and this is crucial to understand the volatility profile of the stock.

**2. Recent Price Movement:**

* **Closing Price:** $550.62 (Last Market: $550.79)
* **5-Day Moving Average:** $538.10
* **20-Day Moving Average:** $524.96
* **60-Day Moving Average:** $500.35

The stock price is trading above all three moving averages, suggesting an upward trend.

**3. Technical Indicators and Expected Return:**

* **RSI (Relative Strength Index):** 83.13 – This indicates the stock is in overbought territory, suggesting a potential pullback.
* **PPO (Percentage Price Oscillator):** 0.19 – A positive value suggests upward momentum, but it's relatively low, not extremely strong.
* **Delta_Previous_Relative_Divergence:** +2.73 – Shows a recent increase in relative strength.
* **Expected Return:** 2.3% – This represents a long-term (2+ years) expected return exceeding the S&P 500, assuming a continued outperformance.  Given the high RSI, this estimate should be treated with caution. The $550.79 closing price is very close to the last market price, thus no major recent up or down swing is apparent.

**4. Recent Financial Performance and Outlook:**

The provided quarterly earnings data shows consistent revenue growth and high profit margins. However, without access to analyst estimates, a comprehensive evaluation of the most recent earnings against expectations cannot be provided.  Further analysis is needed to ascertain if the recent performance surpasses or falls short of projections.

| Date       | EPS    | Revenue       |
|------------|--------|---------------|
| 2024-10-18 | $1.59  | $2.04 Billion |
| 2024-07-19 | $1.48  | $2.01 Billion |
| 2024-04-19 | $1.54  | $1.89 Billion |
| 2023-10-20 | $1.18  | $1.74 Billion |
| 2024-10-18 | $1.18  | $1.74 Billion | *(Note: Duplicate entry)*


**6. Financial Information Analysis:**

The provided financial data reveals strong revenue and profitability (high profit margins), and shows some fluctuation in Return on Equity (ROE), possibly influenced by changes in equity. Further detailed analysis is required to draw strong conclusions, requiring more data points and context.

**7. News and Recent Issues:**

I do not have access to real-time information, including breaking news from sources like Shacknews or Finbold. To obtain the most current news and analyst opinions, please refer to reputable financial news websites and analyst reports.  This section requires information from external sources not available to this model.


**8. Overall Analysis:**

ISRG has demonstrated significant historical outperformance compared to the S&P 500.  However, its current RSI suggests the stock may be overbought, implying a potential short-term correction.  While long-term prospects look promising based on the provided data (high growth, strong margins), the high valuation and overbought conditions warrant caution.  The potential for significant outperformance remains, but the risks of a pullback should be considered, especially with the currently high RSI and the need for confirmation of the recent earnings report against analyst expectations.  Further investigation into the market outlook and analyst ratings is strongly recommended before making any investment decisions.


**9. Disclaimer:** This report is for informational purposes only and should not be considered financial advice.  Always conduct thorough research and consult with a financial professional before making any investment decisions. The accuracy of this report depends entirely on the accuracy and completeness of the input data provided.
